Neo-Endorphin Market
Neo-Endorphin Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Neo-Endorphin Market Size and Growth
The Neo-Endorphin market is experiencing significant growth, driven by increasing demand for pain management and stress relief solutions. As of 2023, the market size is estimated to reach approximately $2.5 billion, with projections indicating continued expansion due to advancements in therapeutic applications and rising consumer awareness of mental health benefits.
Companies Covered
(Covid 19 Impact Covered)
◍ Peptide Institute
◍ Abbexa
◍ Elabscience
◍ Biosynth Carbosynth
◍ Generon.co.uk
◍ Phoenix Pharmaceuticals
◍ Creative Peptides
The Neo-Endorphin market features companies like Peptide Institute, Abbexa, Elabscience, Biosynth Carbosynth, Generon.co.uk, Phoenix Pharmaceuticals, and Creative Peptides. These firms drive growth through peptide development, research support, and innovative applications in therapeutics. Specific sales revenue figures are proprietary, but key players report significant contributions to the peptide synthesis industry.
Request Sample Report
Market Segmentation
By Application
Scientific Research
Medical
Others
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
